BFF
AMGN icon

Byrne Financial Freedom’s Amgen AMGN Stock Holding History

Byrne Financial Freedom’s Portfolio AMGN Stock Details AMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$488K Sell
1,387
-132
-9% -$47.1K 0.23% 57
2025
Q4 		$497K Buy
1,519
+245
+19% +$77.7K 0.23% 58
2025
Q3 		$359K Buy
+1,274
New +$369K 0.18% 70

Other funds holding AMGN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Byrne Financial Freedom's AMGN Position: Q1 2026 in Review

Byrne Financial Freedom reduced its Amgen (AMGN) stake by 8.7% in Q1 2026, selling an estimated $47.1K and leaving 1,387 shares worth $488K. The position accounts for 0.23% of the portfolio, ranked #57.

Byrne Financial Freedom first reported a position in AMGN in Q3 2025 and has held it in 3 quarters since. The position peaked at $497K in Q4 2025. 3,129 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • Byrne Financial Freedom held 1,387 shares of Amgen worth $488K as of Q1 2026.
  • Byrne Financial Freedom sold 132 Amgen shares in Q1 2026, an estimated $47.1K.
  • Amgen made up 0.23% of Byrne Financial Freedom's portfolio in Q1 2026, its #57 holding.
  • Byrne Financial Freedom first reported a position in Amgen in Q3 2025 and has held it in 3 quarters since.
  • Byrne Financial Freedom's Amgen position peaked at $497K in Q4 2025.
  • 3,129 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Byrne Financial Freedom's 13F filing for Q1 2026, filed 27 Apr 2026.